Quest13,

Zenith Epigenetics Ltd (ZEL) is a wholly-owned subsidiary of Zenith Capital Corp (ZCC). Although the whole Zenith enchilada (ZEL + ZCC) may be sold together, it is also possible that just ZEL could be sold off. Under that scenario, current ZCC shareholders would still retain their ZCC shares and ZCC would still retain rights to the Resverlogix royalty preferred shares. Other spin-off scenarios are also possible too that would still allow royalty income to flow into ZCC.

BearDownAZ